Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Iran trong vòng xoáy bất ổn

Iran trong vòng xoáy bất ổn

Phân tích bình luận
(Baothanhhoa.vn) - Từ cuối năm 2025 đến nay, Iran liên tục chìm trong làn sóng biểu tình lan rộng, phản ánh không chỉ những khó khăn kinh tế trước mắt mà còn là cuộc khủng hoảng sâu sắc về niềm tin xã hội và năng lực điều hành của chính quyền. Đồng rial lao dốc, lạm...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh